Risk factors for thiazide-induced hyponatraemia

QJM - Monthly Journal of the Association of Physicians

Volumn 96, Issue 12, 2003, Pages 911-917

  Chow, K M ^a   Szeto, C C ^a   Wong, T Y H ^a   Leung, C B ^a   Li, P K T ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE PLUS HYDROCHLOROTHIAZIDE; BENDROFLUMETHIAZIDE; CHLOROTHIAZIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; INDAPAMIDE; LOOP DIURETIC AGENT; METHYCLOTHIAZIDE; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

ADULT; AGE; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG INDUCED DISEASE; DRUG USE; ELDERLY CARE; FEMALE; GENDER; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPONATREMIA; IMMOBILIZATION; INSTITUTIONALIZATION; KIDNEY FUNCTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PATIENT SELECTION; POTASSIUM BLOOD LEVEL; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; SYMPTOMATOLOGY;

EID: 0348013215     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/hcg157     Document Type: Article

References (52)

1. Gross P, Ketteler M, Hausmann C, Reinhard C, SchoÌmig A, Hackenthal E, Ritz E, Rascher W. Role of diuretics, hormonal derangements, and clinical setting of hyponatremia in medical patients. Klin Wochenschr 1988; 66:662-9.
2. Byatt CM, Millard PH, Levin GE. Diuretics and electrolyte disturbances in 1000 consecutive geriatric admissions. J R Soc Med 1990; 83:704-8.
3. Ashraf N, Locksley R, Arieff AI. Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients. Am J Med 1981; 70:1163-8.
4. Sonnenblick M, Friedlander Y, Rosin AJ. Diuretic-induced severe hyponatremia: review and analysis of 129 reported patients. Chest 1993; 103:601-6.
5. Spital A. Diuretic-induced hyponatremia. Am J Nephrol 1999; 9:447-52.
6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, and the National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 Report. JAMA 2003; 289:2560-72.
7. Subcommittee of WHO/ISH Mild Hypertension Liasion Committee. Summary of 1993 World Health Organization-International Society of Hypertension guidelines for the management of mild hypertension. Br Med J 1993; 307:1541-6.
8. Sever P, Beevers G, Bulpitt C, Lever A, Ramsay L, Reid J, Swales J. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. Br Med J 1993; 306:983-7.
9. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288:2981-97.
10. Appel LJ. The verdict from ALLHAT - thiazide diuretics are the preferred initial therapy for hypertension. JAMA 2002; 288:3039-42.
11. Fuisz RE, Lauler DP, Cohen P. Diuretic-induced hyponatremia and sustained antidiuresis. Am J Med 1962; 33:783-91.
12. Elliott WJ, Weber RR, Murphy MB. A double-blind, randomized, placebo-controlled comparison of the metabolic effects of low-dose hydrochlorothiazide and indapamide. J Clin Pharmacol 1991; 31:751-7.
13. Leonetti G, Rappelli A, Salvetti A, Scapellato L. Long-term effects of indapamide: final results of a two-year Italian multicenter study in systemic hypertension. Am J Cardiol 1990; 65(suppl.):67H-71H.
14. Medical Research Council Working Party on Mild to Moderate Hypertension. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet 1981; ii:539-43.
15. Fusgen I, Schutz D. Use of Indapamide SR in elderly patients in general practice: results of a prospective study of 3034 elderly multimorbid patients. Euro J Ger 2001; 3:165-216.
16. Friedman E, Shadel M, Halkin H, Farfel Z. Thiazide-induced hyponatremia: reproducibility by single dose rechallenge and an analysis of pathogenesis. Ann Intern Med 1989; 110:24-30.
17. DeFronzo RA, Arieff AI. Disorders of sodium metabolism: hyponatremia. In: Arieff AI, DeFronzo RA, eds. Fluid, electrolyte, and acid-base disorders, 2nd edn. New York, Churchill Livingstone, 1995:255-99.
18. Arieff AI, Llach F, Massry SG. Neurological manifestations and morbidity of hyponatremia: correlation with brain water and electrolytes. Medicine (Baltimore) 1978; 2:1251-3.
19. Sterns RH, Ocdol H, Schrier RW, Narins RG. Hyponatremia: pathophysiology, diagnosis, and therapy. In: Narins RG, eds. Maxwell & Kleeman's clinical disorders of fluid and electrolyte metabolism, 5th edn. New York, McGraw-Hill, 1994:583-615.
20. Ellison DH, Okusa MD, Schrier RW. Mechanisms of diuretic action. In: Schrier RW, eds. Diseases of the kidney and urinary tract, 7th edn. Philadelphia, Lippincott Williams & Wilkins, 2001:2423-53.
21. Brater DC. Drug therapy: diuretic therapy. N Engl J Med 1998; 339:387-95.
22. Sonnenblick M, Algur N, Rosin A. Thiazide-induced hyponatremia and vasopressin release. Ann Intern Med 1989; 110:751.
23. Field MJ, Lawrence JR. Complications of thiazide diuretic therapy: an update. Med J Aust 1986; 144:641-4.
24. Sterns RH, Silver SM, Spital A. Hyponatremia. In: Seldin DW, Giebisch G, eds. The Kidney: physiology and pathophysiology, 3rd edn. Philadelphia, Lippincott Williams & Wilkins, 2000:1220.
25. Greenberg A. Diuretic complications. Am J Med Sci 2000; 19:10-24.
26. Roberts CJ, Mitchell JV, Donley AJ. Hyponatraemia: adverse effect of diuretic treatment. Br Med J 1977; 1:210.
27. Pinnock CA. Hyponatraemia associated with hydrochlorothiazide treatment. Br Med J 1978; 1:48.
28. Husby S, Marthedal NJ. Hyponatraemia due to a thiazide diuretic: a case report. Acta Med Scand 1981; 210:523-4.
29. Johnson JE, Wright LF. Thiazide-induced hyponatremia. South Med J 1983; 76:1363-7.
30. Oles KS, Denham JW. Hyponatremia induced by thiazide-like diuretics in elderly. South Med J 1984; 77:1314-15.
31. Collier JG, Webb DJ. Severe thiazide-induced hyponatraemia during treatment with enalapril. Postgrad Med J 1987; 63:1105-6.
32. Canning G, McKillop G, Slater SD. Dilutional hyponatraemia due to hydrochlorothiazide plus amiloride (Moduretic): not to be mistaken for the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Br J Clin Pract 1988; 42:41-2.
33. Chan TY. Indapamide-induced severe hyponatremia and hypokalemia. Ann Pharmacother 1995; 29:1124-8.
34. van Assen S, Mudde AH. Severe hyponatraemia in an amiloride/hydrochlorothiazide-treated patient. Neth J Med 1999; 54:108-13.
35. Kaufman DW, Shapiro S. Epidemiological assessment of drug-induced disease. Lancet 2000; 356:1339-43.
36. Ashouri OS. Severe diuretic-induced hyponatremia in the elderly. Arch Intern Med 1986; 146:1355-7.
37. Abramow M, Cogan E. Clinical aspects and pathophysiology of diuretic-induced hyponatremia. In: Bach JF, Crosnier J, Funck-Brentano JL, GruÌnfeld JP, Maxwell MH, eds. Advances in nephrology, Vol. 13. Chicago, Year Book Medical Publishers, 1984:1-28.
38. Fidler HM, Goldman J, Bielawska CA, Rai GS, Hoffbrand BI. A study of plasma sodium levels in elderly people taking amiloride or triamterene in combination with hydrochlorothiazide. Postgrad Med J 1993; 69:797-9.
39. Mathew TH, Boyd IW, Rohan AP. Hyponatraemia due to the combination of hydrochlorothiazide and amiloride (Moduretic): Australian spontaneous reports 1977-1988. Med J Aust 1990; 152:308-9.
40. Sharabi Y, Illan R, Kamari Y, Cohen H, Nadler M, Messerli FH, Grossman E. Diuretic induced hyponatraemia in elderly hypertensive women. J Hum Hypertens 2002; 16:631-5.
41. Kennedy PGE, Mitchell DM, Hoffbrand BI. Severe hyponatraemia in hospital inpatients. Br Med J 1978; 2:1251-3.
42. Clark BA, Shannon RP, Rosa RM, Epstein FH. Increased susceptibility to thiazide-induced hyponatremia in the elderly. J Am Soc Nephrol 1994; 5:1106-11.
43. Walker RM, Brown RS, Stoff JS. Role of renal prostaglandins during antidiuresis and water diuresis in man. Kidney Int 1981; 21:365-70.
44. Rose BD. New approach to disturbances in the plasma sodium concentration. Am J Med 1986; 81:1033-40.
45. Edelman IS, Liebman J, O'Meara MP, Birkenfeld LW. Interrelations between serum sodium concentration, serum osmolality and total exchangeable sodium, total exchangeable potassium and total body water. J Clin Invest 1958; 37:1236-56.
46. van Kraaij DJW, Jansen RWMM, de Gier JJ, Gribnau FWJ, Hoefnagels WHL. Prescription patterns of diuretics in Dutch community-dwelling elderly patients. Br J Clin Pharmacol 1998; 46:403-7.
47. Onder G, Gambassi G, Landi F, Pedone C, Cesari M, Carbonin PU, Bernabei for Investigators of the GIFA Study. Trends in antihypertensive drugs in the elderly: the decline of thiazides. J Hum Hypertens 2001; 15:291-7.
48. Chang S, Chan WH, Kong Y, Chan GM, Raymond K, Lee A, Lee SC, Critchley JA, Chan JC. Use of indapamide in hospital and community clinics and its effect on plasma potassium in Chinese patients. J Clin Pharm Ther 1998; 23:295-302.
49. Fichman MP, Vorherr H, Kleeman CR, Telfer N. Diuretic-induced hyponatremia. Ann Intern Med 1971; 75:853-63.
50. Kennedy RM, Earley LE. Profound hyponatremia resulting from a thiazide-induced decrease in urinary diluting capacity in a patient with primary polydipsia. N Engl J Med 1970; 282:1185-6.
51. Chan TYK, Chan AYW, Lau JTF, Critchley JAJH. Sodium and potassium intakes and blood pressure in Chinese adults in Hong Kong: a comparison with southern China. Asia Pacific J Clin Nutr 1998; 7:33-6.
52. Woo J, Leung SS, Ho SC, Lam TH, Janus ED. Dietary intake and practices in the Hong Kong Chinese population. J Epidemiol Community Health 1998; 52:631-7.